Community-acquired Pneumonia
📧 Sign up to get email alerts when something new happens for Community-acquired Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Impact on the Use of Antibiotics of a Multimodal Algorithm for the Diagnosis and Management of Acute Community-acquired Pneumonia in the Emergency Room [NA]
The document reports the results/update of a clinical trial evaluating a multimodal diagnostic and management algorithm for acute community-…
-
FDA approval · 2024-10-10FDA Approved: LINEZOLID — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's original ANDA for LINEZOLID (linezolid), making a generic linezolid available in the U.S. fo…
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Cohort Study on the Treatment of Severe Pneumonia with Traditional Chinese Medicine
This clinical trial update describes a cohort study evaluating Traditional Chinese Medicine for the treatment of severe pneumonia. The study…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Clinical Impact of Rapid Molecular Testing for Pathogens in Patients With Severe Acute Respiratory Illness : A Pragmatic Trial [NA]
A pragmatic trial evaluating the clinical impact of rapid molecular testing for pathogens in patients with severe acute respiratory illness,…
-
FDA approval · 2024-08-22FDA Approved: LINEZOLID — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for LINEZOLID (linezolid); the approval finalizes changes to the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Comparison of Efficacy of Oral Amoxicillin Versus Intravenous Ceftriaxone [NA]
This clinical trial compares the efficacy of oral amoxicillin to intravenous ceftriaxone for treating community-acquired pneumonia and is cu…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia [Phase 2]
A Phase 2 trial evaluating presepsin as a biomarker to guide immunotherapy in pneumonia has completed, including community-acquired pneumoni…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: Fulminant Severe CAP - an Observational Study
An observational clinical trial update studying fulminant severe community-acquired pneumonia, including ARDS and sepsis, that is currently …
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia [Phase 3]
Phase 3 randomized, embedded, multifactorial adaptive platform trial evaluating treatments for community-acquired pneumonia, influenza, and …
-
FDA approval · 2024-06-24FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium by Sandoz Inc to support changes to the approved gener…
-
FDA approval · 2024-06-13FDA Approved: ERTAPENEM — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for Ertapenem (ERTAPENEM) by Eugia US LLC. The action relates to a modification/expansion of the dru…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Bacterial Pathogens Associated With Community-acquired Pneumonia in Children
A completed study examining the bacterial pathogens associated with community-acquired pneumonia in children. The trial status indicates the…
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Diagnostic Value of the Biofire®in Community Acquired Pneumonia [NA]
A completed clinical trial evaluating the diagnostic value of the Biofire panel for community-acquired pneumonia.
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: Stopping Pneumonia Antibiotherapy Regimen Early [Phase 4]
Phase 4 clinical trial exploring whether antibiotic therapy for pediatric community-acquired pneumonia can be stopped early.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Molecular Biomarkers for Sepsis
A University Hospital Basel study evaluating molecular biomarkers for sepsis, including severe community-acquired pneumonia, has been termin…
-
FDA approval · 2024-05-01FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for Amoxicillin and clavulanate potassium (amoxicillin-clavulanate) from Northstar RxLLC, authorizin…
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Study of the Efficacy and Safety of Antioxidants Astaxanthin as an Adjuvant Therapy for Community Acquired Pneumonia Patients. [Phase 4]
Clinical trial update for astaxanthin as an adjuvant therapy in community-acquired pneumonia; phase 4, status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries
A retrospective chart review study assessing characteristics, treatment outcomes, and resource use for adults hospitalized with community-ac…
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients [Phase 4]
Phase 4 trial updates the efficacy of intravenous Amboxol hydrochloride as an adjunct therapy for severe pneumonia in critically ill patient…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia [Phase 3]
A Phase 3 trial evaluating the anti-inflammatory effects of oral clarithromycin in community-acquired pneumonia and sepsis has completed.
-
FDA approval · 2023-12-11FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Devatis, Inc.)
FDA approved an Original Application for amoxicillin and clavulanate potassium (amoxicillin/clavulanate) as a generic antibiotic formulation…
-
FDA approval · 2023-09-15FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Devatis, Inc.)
FDA approves a generic amoxicillin/clavulanate potassium product under an Original Application by Devatis, Inc.
-
FDA approval · 2023-09-13FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Devatis Inc.)
FDA approved a generic Amoxicillin and clavulanate potassium product under Original Application by Devatis Inc.
-
FDA approval · 2023-08-16FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
FDA approved Sandoz Inc's supplemental application for clarithromycin, marking a supplemental approval for this generic antibiotic. The acti…
-
FDA approval · 2023-08-16FDA Approved: CLARITHROMYCIN — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for a generic version of clarithromycin produced by Lannett Company, Inc.